ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
The superiority of likelihood-based confidence interval for variance estimation in a single group. [PDF]
Jung SM, Kim M, Bae KS.
europepmc +1 more source
A gentle tutorial on accelerated parameter and confidence interval estimation for hidden Markov models using Template Model Builder. [PDF]
Bacri T +3 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Robust Method for Confidence Interval Estimation in Outlier-Prone Datasets: Application to Molecular and Biophysical Data. [PDF]
Golovko VV.
europepmc +1 more source
[Comparison of 7 methods for sample size determination based on confidence interval estimation for a single proportion]. [PDF]
Yu M, Shi X, Zou B, An S.
europepmc +1 more source
Preference weights with 95% confidence intervals; unforced model, pregnant women.
Tima Mohammadi (8081858) +2 more
openalex +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source

